Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Braz J Microbiol
2022 Jun 01;532:795-799. doi: 10.1007/s42770-022-00706-4.
Show Gene links
Show Anatomy links
Spread of multidrug-resistant Acinetobacter baumannii isolates belonging to IC1 and IC5 major clones in Rondônia state.
Barcelos Valiatti T
,
Silva Carvalho T
,
Fernandes Santos F
,
Silva Nodari C
,
Cayô R
,
da Silva JTP
,
da Silva CC
,
Ferreira JA
,
Moura LB
,
Dos Santos LA
,
Gales AC
.
???displayArticle.abstract???
In Brazil, carbapenem-resistant A. baumannii (CRAB) is a critical pathogen showing high carbapenem resistance rates. Currently, there is little epidemiological data on A. baumannii isolated in the Northern Brazilian region. Herein, this study aimed to characterize the resistance mechanisms of CRAB isolates recovered from hospitalized patients in the state of Rondônia in 2019. Most of CRAB were considered as extensively drug-resistant, and some of them showed high MICs for minocycline. Only polymyxins showed a satisfactory activity. All isolates carried blaOXA-23 and were included in 14 distinct clusters, with the predominance of clonal group A (29%). The IC1 was the most frequent clonal group, followed by IC5 and IC4. Here, we firstly reported the epidemiological scenario of CRAB in the state of Rondônia, located in the Brazilian Amazon region. The high frequency of CRAB presenting XDR phenotype is of great concern, due to limited therapeutical options, especially in the actual pandemic scenario, in which we observed an overcrowding of ICU beds. Such results are essential to better characterize the epidemiology of CRAB in the entire Brazilian territory.
Boettger,
Dynamic of High-Risk Acinetobacter baumannii Major Clones in a Brazilian Tertiary Hospital During a Short Time Period.
2021, Pubmed
Boettger,
Dynamic of High-Risk Acinetobacter baumannii Major Clones in a Brazilian Tertiary Hospital During a Short Time Period.
2021,
Pubmed
Brasiliense,
Emergence of carbapenem-resistant Acinetobacter pittii carrying the blaOXA-72 gene in the Amazon region, Brazil.
2019,
Pubmed
Caldart,
Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016-2018.
2019,
Pubmed
Cardoso,
Diversity of mechanisms conferring resistance to β-lactams among OXA-23-producing Acinetobacter baumannii clones.
2016,
Pubmed
Flamm,
Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).
2016,
Pubmed
Gales,
Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).
2019,
Pubmed
Higgins,
Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
2010,
Pubmed
Higgins,
OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
2013,
Pubmed
Hoban,
Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013.
2015,
Pubmed
Lee,
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
2017,
Pubmed
Martins,
A new trilocus sequence-based multiplex-PCR to detect major Acinetobacter baumannii clones.
2016,
Pubmed
NULL,
2017,
Pubmed
Neves,
Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil.
2016,
Pubmed
Nodari,
Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America.
2020,
Pubmed
Poirel,
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
2006,
Pubmed
Ribeiro,
Phenotypic and molecular detection of the bla KPC gene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil.
2016,
Pubmed
Rocha,
Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces.
2018,
Pubmed
Rodrigues-Costa,
Temporal evolution of Acinetobacter baumannii ST107 clone: conversion of blaOXA-143 into blaOXA-231 coupled with mobilization of ISAba1 upstream occAB1.
2019,
Pubmed
Rossi,
Novel ST1465/CC216 Nosocomial Lineage of Carbapenem-Resistant Acinetobacter baumannii Harboring an Unusual Plasmid Carrying blaNDM-1 Gene.
2021,
Pubmed
Royer,
Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.
2018,
Pubmed
Shinohara,
Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)-specific intensive care unit.
2022,
Pubmed
Tavares,
Emergence and Persistence of High-Risk Clones Among MDR and XDR A. baumannii at a Brazilian Teaching Hospital.
2018,
Pubmed
Vasconcelos,
The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report.
2015,
Pubmed
Vila,
A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex.
1996,
Pubmed
Woodford,
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
2006,
Pubmed
Zarrilli,
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.
2013,
Pubmed
da Silva,
A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit.
2018,
Pubmed
de Azevedo,
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii infection in two hospitals in Central Brazil: the role of ST730 and ST162 in clinical outcomes.
2019,
Pubmed
